Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Véronique Deschamps"'
Autor:
Thierry Schaeverbeke, Bernard Combe, Jean Sibilia, René Marc Flipo, A. Frazier-Mironer, Xavier Mariette, Xavier Le Loët, Véronique Deschamps, Isabelle Logeart, Maxime Dougados, Alain Cantagrel
Publikováno v:
Revue du Rhumatisme. 81:483-490
Resume Objectifs Comparer les taux de retention de l’adalimumab, de l’etanercept et de l’infliximab en tant que biotherapie de 1 re intention dans la polyarthrite rhumatoide (PR), determiner les causes d’arret, les facteurs associes a la rete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f49830d7f74af9159d61f96ed0f13ff
https://doi.org/10.1016/j.rhum.2014.07.001
https://doi.org/10.1016/j.rhum.2014.07.001
Autor:
Maxime Dougados, Xavier Le Loët, A. Frazier-Mironer, Bernard Combe, Alain Cantagrel, Jean Sibilia, René Marc Flipo, Véronique Deschamps, Thierry Schaeverbeke, Xavier Mariette, Isabelle Logeart
Publikováno v:
Joint bone spine. 81(4)
Objectives To compare retention rates of adalimumab, etanercept and infliximab as first-line biotherapy in rheumatoid arthritis (RA), to determine causes of discontinuation, retention-associated factors, and retention rates of possible second-line TN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f6eae9c623313188cd3037a9b04103
https://pubmed.ncbi.nlm.nih.gov/24721422
https://pubmed.ncbi.nlm.nih.gov/24721422
Autor:
Christelle Sordet, B. Combe, Edouard Pertuiset, Eric Toussirot, Véronique Deschamps, Jacques Morel, P. Kieffer, H Champagne, J.-M. Berthelot, Xavier Mariette
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2008, 67 (2), pp.244-7. ⟨10.1136/ard.2007.070086⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2008, 67 (2), pp.244-7. ⟨10.1136/ard.2007.070086⟩
International audience; OBJECTIVE: To date, only a few series of patients with paraneoplastic arthritis have been published. The charts of patients with cancer-associated arthritis were collected in order to describe characteristics of this rheumatis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b30921eb74486de979cfdc16e4fe4b
https://hal.archives-ouvertes.fr/hal-00498193
https://hal.archives-ouvertes.fr/hal-00498193
Publikováno v:
Arthritis Research & Therapy
Synovial hyperplasia in rheumatoid arthritis (RA) has been associated with apoptosis deficiency of RA fibroblast-like synoviocytes (FLSs). Celecoxib is a non-steroidal anti-inflammatory drug that has been demonstrated to induce apoptosis in some cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97e2857d65f08528a90e545a2b5dd60a
https://pubmed.ncbi.nlm.nih.gov/18076767
https://pubmed.ncbi.nlm.nih.gov/18076767
Autor:
B. Combe, Alain Cantagrel, T. Schaeverbeke, Véronique Deschamps, A. Frazier-Mironer, R.M. Flipo, Maxime Dougados, X. Le Loët, J. Sibilia, Isabelle Logeart, Xavier Mariette
Publikováno v:
Annals of the Rheumatic Diseases. 72:A221.4-A222
Background Efficacy and safety of TNFα inhibitors (TNFi) in rheumatoid arthritis (RA) have been evaluated in randomized controlled trials. The analysis of observational studies and registries provides additional real-world information. Drug survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ca2b4203f8809abad37a59de057717f
https://doi.org/10.1136/annrheumdis-2013-eular.701
https://doi.org/10.1136/annrheumdis-2013-eular.701